Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> INFECTION Latest News

APR 25, 2013 - MedPage Today

A Must Read - Share

Once-Daily HCV Drug Stars in Phase III Trials (CME/CE)

AMSTERDAM (MedPage Today) -- Treatment-naive patients with hepatitis C virus infection showed high viral cure rates when treated with simeprevir, a once-daily oral drug, along with standard therapy, researchers said here.

Tags: Once-Daily HCV Drug Stars in Phase III Trials (CME/CE),  Infection Latest News